7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

RedHill Biopharma Ltd
(NASDAQ:RDHL) 

RDHL stock logo

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobac...

Founded: 2009
Full Time Employees: 155
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends
RedHill Biopharma Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 014.7329.4644.1958.9273.6588.38103.11
RedHill Biopharma Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 026.8953.7880.67107.56134.44161.33188.22
RedHill Biopharma Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 023.3846.7670.1393.51116.89140.27163.65
RedHill Biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -18.85-16.16-13.46-10.77-8.08-5.39-2.690
RedHill Biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -18.98-16.27-13.56-10.84-8.13-5.42-2.710
RedHill Biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.843.685.537.379.2111.0512.9
RedHill Biopharma P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.490.981.471.962.452.943.43
RedHill Biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.94-2.51-2.09-1.66-1.24-0.81-0.390.04
RedHill Biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -8.68-7.18-5.67-4.17-2.66-1.160.351.85
No extra charts and metrics for this ticker.